Acute muscular syndrome associated with administration of clofibrate.
D000328:Adult; D000924:Anticholesteremic Agents / Q000009:adverse effects*; D002087:Butyrates / Q000009:adverse effects*; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D005634:Fructose-Bisphosphate Aldolase / Q000097:blood; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008297:Male; D009135:Muscular Diseases / Q000139:chemically induced* / Q000201:enzymology; D000637:Transaminases / Q000097:blood
D000924:Anticholesteremic Agents; D002087:Butyrates; D008074:Lipoproteins; D007770:L-Lactate Dehydrogenase; D000637:Transaminases; D003402:Creatine Kinase; D005634:Fructose-Bisphosphate Aldolase